Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and Acute Kidney Injury.
Research Interests
- Chronic Kidney Disease: Mechanisms of action that reduce proteinuria by enhancing podocyte/endothelial integrity, reduce renal inflammation/fibrosis, and/or enhance tissue regeneration
- Acute Kidney Injury: Opportunities associated with clinical stage assets are of high interest
- Acute Kidney Injury...